Subsequent studies conducted by Junichi Ueyama et al. also confirmed the presence of CREBBP mutation and the activity of the RTK/RAS pathway in relapsed high-hyperdiploid ALL [79,91]. The gene discussed is CREBBP; the disease is acute lymphoblastic leukemia.